APA Zitierstil

Dimopoulos, M. A., Leleu, X., Moreau, P., Richardson, P. G., Liberati, A. M., Harrison, S. J., . . . Yong, K. (2020). Isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients with renal impairment: ICARIA-MM subgroup analysis. Leukemia.

Chicago Zitierstil

Dimopoulos, Meletios A., et al. "Isatuximab Plus Pomalidomide and Dexamethasone in Relapsed/refractory Multiple Myeloma Patients With Renal Impairment: ICARIA-MM Subgroup Analysis." Leukemia 2020.

MLA Zitierstil

Dimopoulos, Meletios A., et al. "Isatuximab Plus Pomalidomide and Dexamethasone in Relapsed/refractory Multiple Myeloma Patients With Renal Impairment: ICARIA-MM Subgroup Analysis." Leukemia 2020.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.